LpA-II:B:C:D:E: a new immunochemically-defined acute phase lipoprotein in humans.
John D BagdadeBernd JilmaLisa C HudginsPetar AlaupovicCarrie E McCurdyPublished in: Lipids in health and disease (2018)
We have identified a new acute phase lipoprotein whose apoprotein constituents have metabolic and immunoregulatory properties applicable to host defense that make it well constituted to engage in the APR.
Keyphrases